Los estudios sugieren que el CBD tiene propiedades para reducir la severidad y frecuencia de ataques epilépticos en niños resistentes a fármacos creados para este fin. El número de ensayos clínicos realizados para elucidar la efectividad del CBD va en aumento, ya que se necesita metodología más robusta y mayor número de pacientes para poder conocer el real potencial de este compuesto.
Most of the products claim to ease pain and anxiety. But whether or not these products actually contain the amount of CBD they advertise is up for debate, since they're not approved by the FDA. In 2015 the FDA tested CBD products from companies making unfounded health claims, and found that many of them didn't even have the amount of CBD they'd advertised.
In making the two previous determinations about THC, why did FDA conclude that THC is an active ingredient in a drug product that has been approved under section 505 of the FD&C Act? In making the two previous determinations about CBD, why did FDA determine that substantial clinical investigations have been authorized for and/or instituted, and that the existence of such investigations has been made public?